Senior insider sale
EVP and Chief Medical Officer at VIR BIOTECHNOLOGY, INC. — senior position signals high conviction
$965.8K
94.55K shares
What this filing means
EISNER MARK plans to sell 94.55K shares of VIR BIOTECHNOLOGY, INC. valued at approximately $965.8K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 4/30/2026ACC: 0001959173-26-003135
Officer· EVP and Chief Medical Officer
Since Feb 2026
94.55K
Shares to sell
$965.8K
Approx. market value
88.96K
Acquired (3 months)
1
Planned
3 completed
Securities Acquired — Last 3 Months2
Option Granted - 02/22/2025
Cash
4/30/2026
23.33KOption Granted - 07/15/2024
Cash
4/30/2026
65.63KTotal acquired88.96K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
4/30/2026 | Option Granted - 02/22/2025 Cash | 23.33K | — |
4/30/2026 | Option Granted - 07/15/2024 Cash | 65.63K | — |
| Total | 88.96K | ||
Planned & Completed Dispositions4
Completed
—Completed
Units to sell
1.89K
Market value
$18.5K
2/25/2026
—Completed
Units to sell
1.62K
Market value
$15.4K
2/24/2026
—Completed
Units to sell
2.09K
Market value
$15.6K
2/23/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
88.96K
Market value
$916.3K
4/30/2026
Total
Units
94.55K
Value
$965.8K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
2/25/2026 | 1.89K | $18.5K | — | Completed |
2/24/2026 | 1.62K | $15.4K | — | Completed |
2/23/2026 | 2.09K | $15.6K | — | Completed |
| Planned — Approximate Date | ||||
4/30/2026 | 88.96K | $916.3K | NASDAQ | Planned |
| Total | 94.55K | $965.8K | ||